Target intelligence / Profile preview

Methylation pathway (OCM)

Target
OCM
Molecular classification
Enzyme, Metabolic pathway, Epigenetic regulator
01

Overview

The methylation pathway, also known as one-carbon metabolism, is a fundamental biochemical network that facilitates the transfer of methyl groups to DNA, proteins, and lipids (Ducker & Rabinowitz, 2017). It integrates the folate and methionine cycles to produce S-adenosylmethionine (SAM), the universal methyl donor required for epigenetic regulation and cellular maintenance (Lu, 2000). This pathway is vital for DNA synthesis, repair, and the regulation of gene expression through DNA and histone methylation (Moore et al., 2013). Dysregulation of the pathway is a hallmark of various diseases, particularly cancer, where it contributes to oncogene activation or tumor suppressor silencing (Jones & Baylin, 2002). It is also critically involved in cardiovascular health by managing homocysteine levels and in neurological function through the synthesis of neurotransmitters like serotonin and dopamine (Selhub, 1999). Pharmacological modulation of the pathway includes the use of DNA methyltransferase inhibitors for treating myelodysplastic syndromes and folate antagonists for cancer and autoimmune diseases (Gore et al., 2006).

Other names
One-carbon metabolismFolate-methionine cycleSAM cycleBiological methylation
02

Mechanism of action

Inhibition of DNA methyltransferases (DNMTs), inhibition of histone methyltransferases (HMTs), inhibition of folate metabolism enzymes (e.g., DHFR), and provision of methyl donors or metabolic precursors.

03

Biological functions

Epigenetic regulationNucleotide synthesisAmino acid metabolismRedox homeostasisNeurotransmitter synthesis
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseCongenital defectInflammation
05

Safety considerations

MyelosuppressionHepatotoxicityTeratogenicityHyperhomocysteinemiaOff-target epigenetic modifications
06

Interacting drugs

Azacitidine

7 more in the full profile.

07

Biomarkers

Plasma homocysteineS-adenosylmethionine (SAM) levelsMTHFR C677T polymorphismMGMT promoter methylationGlobal DNA methylation (5-mC)

Beyond the preview

Go deeper on Methylation pathway (OCM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methylation pathway (OCM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call